Literature DB >> 25316034

The unified protocol for transdiagnostic treatment of emotional disorders: preliminary exploration of effectiveness for group delivery.

Jacqueline R Bullis1, Shannon Sauer-Zavala2, Kate H Bentley2, Johanna Thompson-Hollands2, Jenna R Carl2, David H Barlow2.   

Abstract

The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP) has demonstrated promising results among patients with heterogeneous anxiety and comorbid depressive disorders when delivered on an individual basis, but greater efficiencies may be achieved with group-based applications. The aim of the present study was to provide a preliminary exploration of the UP when delivered in a group format. Among diagnostically diverse patients (N = 11), the UP group treatment resulted in moderate to strong effects on anxiety and depressive symptoms, functional impairment, quality of life, and emotion regulation skills, as well as good acceptability and overall satisfaction ratings from patients. Three clinical cases are presented in detail to illustrate the group-based UP delivery, followed by a critical discussion of associated challenges and proposed guidelines for group administration, as well as directions for future research.
© The Author(s) 2014.

Entities:  

Keywords:  anxiety disorders; cognitive-behavioral treatment; group therapy; transdiagnostic; unified protocol

Mesh:

Year:  2014        PMID: 25316034     DOI: 10.1177/0145445514553094

Source DB:  PubMed          Journal:  Behav Modif        ISSN: 0145-4455


  8 in total

Review 1.  Emergence of Transdiagnostic Treatments for PTSD and Posttraumatic Distress.

Authors:  Cassidy A Gutner; Tara Galovski; Michelle J Bovin; Paula P Schnurr
Journal:  Curr Psychiatry Rep       Date:  2016-10       Impact factor: 5.285

Review 2.  The Impact of Group Emotion Regulation Interventions on Emotion Regulation Ability: A Systematic Review.

Authors:  Rebekah Moore; David Gillanders; Simon Stuart
Journal:  J Clin Med       Date:  2022-04-29       Impact factor: 4.964

3.  Transdiagnostic group CBT vs. standard group CBT for depression, social anxiety disorder and agoraphobia/panic disorder: Study protocol for a pragmatic, multicenter non-inferiority randomized controlled trial.

Authors:  Sidse M Arnfred; Ruth Aharoni; Morten Hvenegaard; Stig Poulsen; Bo Bach; Mikkel Arendt; Nicole K Rosenberg; Nina Reinholt
Journal:  BMC Psychiatry       Date:  2017-01-23       Impact factor: 3.630

4.  Efficacy of the unified protocol for the treatment of emotional disorders in the Spanish public mental health system using a group format: study protocol for a multicenter, randomized, non-inferiority controlled trial.

Authors:  Jorge Osma; Carlos Suso-Ribera; Azucena García-Palacios; Elena Crespo-Delgado; Cristina Robert-Flor; Ana Sánchez-Guerrero; Vanesa Ferreres-Galan; Luisa Pérez-Ayerra; Amparo Malea-Fernández; Mª Ángeles Torres-Alfosea
Journal:  Health Qual Life Outcomes       Date:  2018-03-12       Impact factor: 3.186

5.  Experiences of a transdiagnostic group, the Take Control Course, for clients with common mental health problems: A qualitative study.

Authors:  Lydia Morris; Warren Mansell; Rebekah Amos; Dawn Edge
Journal:  Clin Psychol Psychother       Date:  2018-06-26

6.  What format of treatment do patients with emotional disorders prefer and why? Implications for public mental health settings and policies.

Authors:  Jorge Osma; Carlos Suso-Ribera; Óscar Peris-Baquero; Marta Gil-Lacruz; Luisa Pérez-Ayerra; Vanesa Ferreres-Galan; Mª Ángeles Torres-Alfosea; María López-Escriche; Olga Domínguez
Journal:  PLoS One       Date:  2019-06-10       Impact factor: 3.240

7.  The efficacy of transdiagnostic cognitive behavioral therapy on migraine headache: a pilot, feasibility study.

Authors:  Forouzandeh Soleimanian-Boroujeni; Negin Badihian; Shervin Badihian; Vahid Shaygannejad; Yousef Gorji
Journal:  BMC Neurol       Date:  2022-06-22       Impact factor: 2.903

8.  Transdiagnostic treatment of emotional disorders for women with multiple sclerosis: a randomized controlled trial.

Authors:  Nabi Nazari; Akram Aligholipour; Masoud Sadeghi
Journal:  BMC Womens Health       Date:  2020-10-31       Impact factor: 2.809

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.